Cytokinetics
CYTK
CYTK
343 hedge funds and large institutions have $7.34B invested in Cytokinetics in 2024 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 156 increasing their positions, 92 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding in top 10
Funds holding in top 10: →
11% less capital invested
Capital invested by funds: $8.26B → $7.34B (-$918M)
12% less funds holding
Funds holding: 388 → 343 (-45)
49% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 84
Holders
343
Holding in Top 10
20
Calls
$199M
Puts
$130M
Top Buyers
| 1 | +$276M | |
| 2 | +$213M | |
| 3 | +$182M | |
| 4 |
BlackRock
New York
|
+$136M |
| 5 |
State Street
Boston,
Massachusetts
|
+$122M |
Top Sellers
| 1 | -$53M | |
| 2 | -$49.6M | |
| 3 | -$48.9M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$36.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$34.6M |